- Home
- Services
- united kingdom
- therapeutic blocking anaphylatoxin receptor antibodies
Show results for
Refine by
Therapeutic Blocking Anaphylatoxin Receptor Antibodies Services In United Kingdom
5 services found
Manufactured by:Absolute Antibody Ltd based inRedcar, UNITED KINGDOM
Absolute Antibody offers a quick and professional hybridoma sequencing service, also known as antibody sequencing. Hybridoma sequencing is the sequencing of the cDNA encoding the variable heavy (VH) and variable light (VL) domains of your hybridoma cell ...
Manufactured by:Absolute Antibody Ltd based inRedcar, UNITED KINGDOM
Humanization is a critical step in the development pathway of all therapeutic antibodies derived from non-human sources, such as hybridomas. Absolute Antibody’s Prometheus™ antibody humanization service delivers a panel of humanized variants from your clone, guaranteeing to produce a variant with comparable activity to the parent antibody. Our service focuses on enhancing antibody ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Creative Biolabs has extensive experience to offer the novel human or humanized antibody services for either therapeutic or laboratory applications. We have three routes in developing human antibodies. The first and most straightforward method is to screen our human antibody libraries. The second method is to immunize premade “humanized” mice and then raise hybridoma cell lines [or to ...
Manufactured by:Absolute Antibody Ltd based inRedcar, UNITED KINGDOM
Polyclonal antibodies are widely used reagents across research and diagnostics. They are generated by immunizing animals with an immunogen and harvesting the animals’ blood to obtain immunoreactive serum. While polyclonal antibodies offer a range of advantages such as excellent performance across different methods, they suffer from high batch-to-batch variability and require the continued ...
Manufactured by:Fluidic Sciences Ltd based inHertfordshire, UNITED KINGDOM
Fluidic Sciences Ltd. offers the Fluidity One-M instrument, integrated with Microfluidic Diffusional Sizing (MDS) technology, specifically engineered for in-solution analysis of antibodies and their targets throughout various stages of development. The device is designed to ensure stability optimization, target specificity, and modulation of immune responses necessary for therapeutic antibodies, ...